Buoyed by positive gains for shares of Amgen and Merck, the Dow Jones Industrial Average is climbing Tuesday morning. Supported by world-class markets data from Dow Jones and FactSet, and partnering ...

Another LIV golfer has quit during Open Final Qualifying after a tough first round left him well behind the early leaders.

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Responding to the European Commission’s call for evidence, Biovia says regulatory delays, fragmented markets, and lack of capital are costing Europe its biotech edge.

Fresenius announced today that its operating company Fresenius Kabi, has introduced two new biosimilars - Conexxence® ...

The market, which was valued at $0.85 billion in 2024, is projected to grow to $0.91 billion in 2025, representing a compound annual growth rate CAGR of 7.2%. The growth during this historic period ...

In February 2025 Harbour BioMed announced that the IND application for HBM9378 (SKB378), a TSLP-targeting monoclonal antibody ...

Emerging oligonucleotides and gene editing therapies offer greater precision, long-term efficacy, and improved adherence in ...

Detroit Lions legend Barry Sanders has let a terrifying personal experience guide him to advocate for a very important cause ...

The investment signals confidence in Levelpath's fast growth and its potential to disrupt a market dominated by legacy ...

Mirae Asset Global Investments trimmed its Amgen holdings by 1.5% in the first quarter, selling 7,398 shares. This reduction ...